Clinical Trial Update: The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for the HeLiX trial evaluating tranexamic acid to reduce hemorrhage during liver resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Liver Cancer
• Surgical Cancer
• Tumor

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Cancer, Tumour | Phase 3 | Status: ACTIVE_NOT_RECRUITING